Asthika Goonewardene
Stock Analyst at Truist Financial
(3.25)
# 2,449
Out of 4,534 analysts
322
Total ratings
42.1%
Success rate
2.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $45 → $32 | $28.22 | +12.47% | 5 | Jun 22, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | n/a | $7.89 | - | 14 | Mar 16, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $10 | $1.77 | +464.97% | 20 | Mar 13, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $155 | $92.16 | +68.19% | 19 | Mar 13, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $70 | $23.21 | +201.59% | 10 | Mar 13, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | n/a | $180.39 | - | 9 | Mar 9, 2026 | |
| CRBU Caribou Biosciences | Reiterated: Buy | $7 | $1.62 | +332.10% | 11 | Mar 9, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $2.34 | +70.94% | 20 | Mar 3, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 | $23.76 | +68.35% | 4 | Mar 3, 2026 | |
| SEPN Septerna | Maintained: Buy | n/a | $32.21 | - | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $28.17 | +6.50% | 22 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.02 | - | 28 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $27.91 | +71.98% | 40 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.50 | +159.26% | 19 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $55.53 | -8.16% | 30 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $1.40 | +471.43% | 25 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.59 | - | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127 → $145 | $133.21 | +8.85% | 12 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $207.66 | n/a | 1 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.25 | n/a | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.78 | n/a | 6 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $15 | $5.40 | n/a | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 267.99 → kr 346.43 | kr 1,855 | n/a | 2 | Jul 14, 2022 |
ArriVent BioPharma
Jun 22, 2026
Reiterated: Buy
Price Target: $45 → $32
Current: $28.22
Upside: +12.47%
Adicet Bio
Mar 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.89
Upside: -
Allogene Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $10
Current: $1.77
Upside: +464.97%
BioNTech SE
Mar 13, 2026
Maintained: Buy
Price Target: $155
Current: $92.16
Upside: +68.19%
Legend Biotech
Mar 13, 2026
Maintained: Buy
Price Target: $70
Current: $23.21
Upside: +201.59%
Revolution Medicines
Mar 9, 2026
Maintained: Buy
Price Target: n/a
Current: $180.39
Upside: -
Caribou Biosciences
Mar 9, 2026
Reiterated: Buy
Price Target: $7
Current: $1.62
Upside: +332.10%
Compugen
Mar 3, 2026
Reiterated: Buy
Price Target: $4
Current: $2.34
Upside: +70.94%
Zymeworks
Mar 3, 2026
Reiterated: Buy
Price Target: $40
Current: $23.76
Upside: +68.35%
Septerna
Mar 2, 2026
Maintained: Buy
Price Target: n/a
Current: $32.21
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $30
Current: $28.17
Upside: +6.50%
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $5.02
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $27.91
Upside: +71.98%
Feb 24, 2026
Reiterated: Buy
Price Target: $35
Current: $13.50
Upside: +159.26%
Jan 14, 2026
Reiterated: Buy
Price Target: $51
Current: $55.53
Upside: -8.16%
Jan 13, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $1.40
Upside: +471.43%
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $22.59
Upside: -
Nov 3, 2025
Reiterated: Buy
Price Target: $127 → $145
Current: $133.21
Upside: +8.85%
Apr 24, 2024
Maintained: Hold
Price Target: n/a
Current: $207.66
Upside: n/a
Mar 21, 2024
Rated: Hold
Price Target: n/a
Current: $7.25
Upside: n/a
Jan 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.78
Upside: n/a
Aug 23, 2022
Maintained: Buy
Price Target: $19 → $15
Current: $5.40
Upside: n/a
Jul 14, 2022
Maintained: Buy
Price Target: kr 267.99 → kr 346.43
Current: kr 1,855
Upside: n/a